Literature DB >> 12915612

Pamidronate for early-stage, untreated myeloma.

Pellegrino Musto, Antonietta Falcone, Grazia Sanpaolo, Carlo Bodenizza, Angelo Michele Carella.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12915612     DOI： 10.1200/JCO.2003.99.248

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

Review 1.  The Changing Landscape of Smoldering Multiple Myeloma: A European Perspective.

Authors:  Jo Caers; Carlos Fernández de Larrea; Xavier Leleu; Roy Heusschen; Niklas Zojer; Olivier Decaux; Efstathios Kastritis; Monique Minnema; Artur Jurczyszyn; Yves Beguin; Ralph Wäsch; Antonio Palumbo; Meletios Dimopoulos; Maria Victoria Mateos; Heinz Ludwig; Monika Engelhardt
Journal:  Oncologist       Date:  2016-02-26

Review 2.  Bone disease from monoclonal gammopathy of undetermined significance to multiple myeloma: pathogenesis, interventions, and future opportunities.

Authors:  Alex R Minter; Haley Simpson; Brendan M Weiss; Ola Landgren
Journal:  Semin Hematol       Date:  2011-01       Impact factor: 3.851

Review 3.  Bone disease in multiple myeloma and precursor disease: novel diagnostic approaches and implications on clinical management.

Authors:  Sigurdur Y Kristinsson; Alex R Minter; Neha Korde; Esther Tan; Ola Landgren
Journal:  Expert Rev Mol Diagn       Date:  2011-07       Impact factor: 5.225

4.  How I treat smoldering multiple myeloma.

Authors:  Irene M Ghobrial; Ola Landgren
Journal:  Blood       Date:  2014-10-08       Impact factor: 22.113

5.  The road to cure in multiple myeloma starts with smoldering disease.

Authors:  Karma Z Salem; Irene M Ghobrial
Journal:  Expert Opin Orphan Drugs       Date:  2015-04-12       Impact factor: 0.694

6.  A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myeloma.

Authors:  Stina Wichert; Gunnar Juliusson; Åsa Johansson; Elisabeth Sonesson; Ingrid Teige; Anna Teige Wickenberg; Björn Frendeus; Magnus Korsgren; Markus Hansson
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.